Lourdes Felix
Directeur Général chez BIOCORRX INC.
Fortune : 96 603 $ au 31/05/2024
Profil
Lourdes Felix is the founder of BioCorRx Pharmaceuticals, Inc. She currently holds multiple positions as an Independent Director in various companies including Siyata Mobile, Inc., Lichen China Ltd., Vocodia Holdings Corp., Avalon GloboCare Corp., and La Rosa Holdings Corp.
Additionally, she serves as the Director, CFO, Chief Executive & Operating Officer at BioCorRx, Inc. Ms. Felix completed her undergraduate degree at the University of Phoenix in 2005 and holds an MBA from D'Amore-Mckim School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BIOCORRX, INC.
0,84% | 28/03/2024 | 80 395 ( 0,84% ) | 56 678 $ | 31/05/2024 |
BIOCORRX, INC.
25,00% | 25/03/2024 | 40 000 ( 25,00% ) | 28 200 $ | 31/05/2024 |
BIOCORRX, INC.
12,50% | 25/03/2024 | 10 000 ( 12,50% ) | 7 050 $ | 31/05/2024 |
| 04/04/2024 | 2 500 ( 0,01% ) | 4 025 $ | 31/05/2024 | |
Vocodia Holdings Corp.
 Vocodia Holdings Corp. Packaged SoftwareTechnology Services Vocodia Holdings Corp. engages in the provision of conversational artificial intelligence technology. The firm is also involved in building practical artificial intelligence functions and makes them easily obtainable for businesses on cloud-based platform solutions at low costs and scalable to multiagent vast enterprise solutions. The company was founded by Brian Podolak and James Sposato on April 27, 2021 and is headquartered in Boca Raton, FL. 0,01% | 14/02/2024 | 5 000 ( 0,01% ) | 650 $ | 31/05/2024 |
AVALON GLOBOCARE CORP.
-.--% | 29/03/2024 | 0 ( -.--% ) | - $ | 31/05/2024 |
Postes actifs de Lourdes Felix
| Sociétés | Poste | Début |
|---|---|---|
| BIOCORRX INC. | Directeur Général | 09/11/2020 |
| SIYATA MOBILE INC. | Directeur/Membre du Conseil | 29/10/2021 |
| LICHEN CHINA LIMITED | Directeur/Membre du Conseil | - |
| AVALON GLOBOCARE CORP. | Directeur/Membre du Conseil | 09/01/2023 |
| LA ROSA HOLDINGS CORP. | Directeur/Membre du Conseil | 19/04/2024 |
BioCorRx Pharmaceuticals, Inc.
 BioCorRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of BioCorRx, Inc., BioCorRx Pharmaceuticals, Inc. is a biopharmaceutical company specializing in developing treatments for substance use disorder. The company is based in Anaheim, CA. The lead candidate is a naltrexone pellet implanted subcutaneously being developed to address both opioid and alcohol use disorders. The company is seeking FDA approval of the naltrexone pellet and exploring other products for regulatory approval. The CEO is Brady James Granier, and the company was founded by Lourdes Felix. | Fondateur | - |
Vocodia Holdings Corp.
Vocodia Holdings Corp. Packaged SoftwareTechnology Services Vocodia Holdings Corp. engages in the provision of conversational artificial intelligence technology. The firm is also involved in building practical artificial intelligence functions and makes them easily obtainable for businesses on cloud-based platform solutions at low costs and scalable to multiagent vast enterprise solutions. The company was founded by Brian Podolak and James Sposato on April 27, 2021 and is headquartered in Boca Raton, FL. | Directeur/Membre du Conseil | 22/02/2024 |
Formation de Lourdes Felix
| University of Phoenix | Undergraduate Degree |
| D'Amore-Mckim School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 6 |
|---|---|
| BIOCORRX INC. | Health Services |
| SIYATA MOBILE INC. | Electronic Technology |
| LICHEN CHINA LIMITED | Commercial Services |
| AVALON GLOBOCARE CORP. | Health Technology |
 | Technology Services |
| LA ROSA HOLDINGS CORP. | Finance |
| Entreprise privées | 1 |
|---|---|
BioCorRx Pharmaceuticals, Inc.
BioCorRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of BioCorRx, Inc., BioCorRx Pharmaceuticals, Inc. is a biopharmaceutical company specializing in developing treatments for substance use disorder. The company is based in Anaheim, CA. The lead candidate is a naltrexone pellet implanted subcutaneously being developed to address both opioid and alcohol use disorders. The company is seeking FDA approval of the naltrexone pellet and exploring other products for regulatory approval. The CEO is Brady James Granier, and the company was founded by Lourdes Felix. | Health Technology |
